Capnography Devices Market Size

Capnography Devices Market Analysis

The Capnography Devices Market size is estimated at USD 584.47 million in 2024, and is expected to reach USD 829.37 million by 2029, growing at a CAGR of 7.25% during the forecast period (2024-2029).

• COVID-19 disease significantly impacted capnography devices. During the early pandemic in 2020, there had been a slight decline in market growth due to the lack of availability of the devices. This had been primarily due to the supply chain restrictions and manufacturing halts because of stringent lockdowns across the globe. But, during the late pandemic, there had been a huge surge in market growth due to the rising adoption of capnography devices in the management and detection of COVID-19 disease.
• Furthermore, according to the study published in Respiratory Physiology and Neurobiology in December 2020, capnography is a convenient bedside approach for monitoring patients' split ventilation. Such advantages of capnography during the pandemic have led to increased adoption of capnography devices during the late pandemic phase. Furthermore, post-pandemic, the market is expected to show a significant pace due to the adoption of capnography devices for various lung diseases such as respiratory infections, asthma, and chronic obstructive lung pulmonary disease.
• The major factors driving the market growth include the rising number of surgeries across the globe, the increasing prevalence of respiratory diseases, and technological advancements in capnography devices, among others.
• Respiratory diseases, such as respiratory infections, asthma, lung cancer, and Chronic obstructive pulmonary disease (COPD), are increasing at an alarming rate in both developed and developing countries, which is driving the growth of the market. Chronic respiratory diseases are found to affect the airways and other parts of the lungs for a longer duration of the period. Respiratory symptoms are among the major causes of consultation with doctors and physicians in primary health care centers. According to the Global Initiative for Chronic Obstructive Lung Disease 2022, COPD is thought to affect 200 million people, and asthma affects 262 million people globally.
• In addition, according to the ERS International Congress 2021, it is estimated that the number of COPD patients in European regions such as Germany, the United Kingdom, Spain, and Italy would be 7.6 million, 7 million, 4.8 million, and 4.7 million, respectively, by 2050. Such a huge prevalence of respiratory devices is anticipated to drive market growth due to the rising adoption of capnography devices during the management of COPD
• Furthermore, the rising demand for capnography devices and key initiatives adopted by the market players is anticipated to rise in adoption, driving market growth. For instance, in November 2021, Smile Train and Lifebox started developing capnography equipment specifically for low-resource settings in an effort to increase the safety of anesthesia for kids worldwide. The goal of this endeavor is to locate and acquire a reliable, user-friendly, and reasonably priced capnography device that will aid in enhancing anesthetic safety for kids all over the world.
• Thus, the increasing prevalence of respiratory diseases, technological advancement in the products, and rising initiatives from the market players have augmented the demand for capnography devices, which is expected to drive the growth of the market. However, the shortage of skilled professionals and the high cost of devices are the factors expected to hinder market growth.